The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord-Reference-Cited by-同舟云学术

The epigenetic drug Trichostatin A ameliorates experimental autoimmune encephalomyelitis via T cell tolerance induction and impaired influx of T cells into the spinal cord

Published:2017-12 Issue: Volume:108 Page:1-12
ISSN:0969-9961
Container-title:Neurobiology of Disease
language:en
Short-container-title:Neurobiology of Disease

Author:

Jayaraman Arathi,Soni Advait,Prabhakar Bellur S.,Holterman Mark,Jayaraman Sundararajan^ORCID

Publisher

Elsevier BV

Subject

Neurology

Reference55 articles.

1. The molecular hallmarks of epigenetic control;Allis;Nat. Rev. Genet.,2016

2. Type I interferons: beneficial in Th1 and detrimental in Th17 autoimmunity;Axtell;Clin Rev Allergy Immunol,2013

3. Reversal of axonal loss and disability in a mouse model of progressive multiple sclerosis;Basso;J. Clin. Invest.,2008

4. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand;Bielekova;Nat. Med.,2000

5. Transcriptional therapy with the histone deacetylase inhibitor trichostatin A ameliorates experimental autoimmune encephalomyelitis;Camelo;J. Neuroimmunol.,2005

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induction of indoleamine 2,3-dioxygenase 1 expression in neurons of the central nervous system through inhibition of histone deacetylases blocks the progression of experimental autoimmune encephalomyelitis;International Immunopharmacology;2024-06

2. Interferon-gamma ameliorates experimental autoimmune encephalomyelitis by inducing homeostatic adaptation of microglia;Frontiers in Immunology;2023-06-02

3. Targeting the catalytic activity of HDAC1 in T cells protects against experimental autoimmune encephalomyelitis;2023-04-14

4. Impact of histone modifier-induced protection against autoimmune encephalomyelitis on multiple sclerosis treatment;Frontiers in Neurology;2022-10-14

5. Epigenetic drug ameliorated type 1 diabetes via decreased generation of Th1 and Th17 subsets and restoration of self-tolerance in CD4+ T cells;International Immunopharmacology;2022-02